Decreased All-Cause and Liver-Related Mortality Risk in HIV/Hepatitis B Virus Coinfection Coinciding With the Introduction of Tenofovir-Containing Combination Antiretroviral Therapy

BACKGROUND: The development of efficacious combination antiretroviral therapy (cART) has led to a dramatic decrease in mortality in HIV-positive patients. Specific data on the impact in HIV/hepatitis B virus (HBV)–coinfected patients are lacking. In this study, all-cause and cause-specific mortality...

Descripción completa

Detalles Bibliográficos
Autores principales: van Welzen, Berend J, Smit, Colette, Boyd, Anders, Lieveld, Faydra I, Mudrikova, Tania, Reiss, Peter, Brouwer, Annemarie E, Hoepelman, Andy I M, Arends, Joop E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Major Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7340797/
https://www.ncbi.nlm.nih.gov/pubmed/32665961
http://dx.doi.org/10.1093/ofid/ofaa226

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7340797/
https://www.ncbi.nlm.nih.gov/pubmed/32665961
http://dx.doi.org/10.1093/ofid/ofaa226

Ejemplares similares